The purpose of the study is to assess the presence and level of antibodies, which are proteins in the blood that fight infections, against the circulating influenza virus strains and the vaccine strains of the current season. Participants will receive the vaccine through an injection into the muscle. Blood samples will be taken before and after vaccination to measure the immune response. The study will also look at cellular immunity, which involves the body’s cells responding to the virus, and will measure substances like cytokines, which are proteins that help control the immune response.

The study will take place over several years, with the goal of understanding how well the vaccine works in healthcare workers who are regularly exposed to the flu. This information could help improve future flu vaccines and protect people from getting sick. Participants will be monitored throughout the study to ensure their safety and to gather important data on how their bodies respond to the vaccine.

The purpose of the study is to analyze the immediate effect of these antiseptics on the viral load in saliva and to determine how long this effect lasts, up to 7 hours after a single rinse. Participants will use the mouthwash, and samples of their saliva will be collected at different times to measure the amount of virus present. This will help researchers understand the potential of these antiseptics in reducing the spread of respiratory viruses.

The study will involve participants who have been diagnosed with one of the mentioned respiratory viruses and have shown symptoms for less than 5 days. The trial will not include those who are currently receiving antiviral treatments. The findings from this study could provide valuable insights into the use of oral antiseptics as a simple method to help control the spread of respiratory infections.

The purpose of the study is to determine if stopping antibiotics early in cases of viral pneumonia, which is a type of lung infection, can reduce the overall use of antibiotics after one month. Participants in the study will receive either the standard antibiotic treatment or a placebo, and their progress will be monitored over a period of time. The study will look at various outcomes, including the number of days without antibiotics, any side effects from the antibiotics, and other health complications that may arise during hospitalization.

Throughout the study, participants will be closely observed to ensure their safety and to gather data on the effectiveness of early antibiotic discontinuation. The study will also assess the impact on the duration of hospital stays and overall health outcomes, such as mortality rates and the ability to perform daily activities. The findings from this study could help improve treatment strategies for elderly patients with viral infections, potentially leading to better health outcomes and reduced antibiotic use.